Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 1081 - 1088 of 12065 results

Major Win for California Privacy Protection Agency: Enforcement of Regulations Can Begin Immediately
February 15, 2024| Blog| Viewpoint

USCIS Fee Increases May Have Unintended Consequences
February 15, 2024| News

Hiring Across the 49th Parallel: Traps for the Unwary for Cross-Border US-Canada Hires
February 14, 2024| Blog| Viewpoint

USCIS Online Organizational Accounts and Electronic Filing – the Future has Finally Arrived – Session 1
February 14, 2024| Webinar| Viewpoint

US Judges Are Warning Implementers To Take FRAND Negotiations Seriously, Or Else
February 14, 2024| News

Bitcoin ETF Approval Doesn't Mean SEC Approves Of Crypto
February 13, 2024| News

Frequently Asked Questions for Private Companies Considering a Reverse Merger
February 13, 2024| Article| Viewpoint

EPA's Latest PFAS Action Leaves Unanswered Questions
February 13, 2024| News
News & Press Releases
Mintz Advises PHLUR on Acquisition by TSG Consumer
July 29, 2025
Mintz advised PHLUR, a modern fragrance brand recognized for its emotion-led storytelling and accessible positioning, in its acquisition by TSG Consumer, a leading private equity firm specializing in consumer brands.
Mintz Attorneys Named to Los Angeles Business Journal’s 2025 “Leaders of Influence: Litigators & Trial Attorneys” List
July 28, 2025
Mintz Member Esteban Moralesand Special Counsel Nada Shamonki has been recognized by Los Angeles Business Journal in its 2025 “Leaders of Influence: Litigators & Trial Attorneys” list which recognizes lawyers who “go to the proverbial mat to fight for their clients,” according to the publication.
Is Biopharma M&A In a Holding Pattern or a ‘New Normal’
July 23, 2025
Life Sciences International Chair Cheryl Reicin recently joined the Scrip M&A Podcast to share insights on the evolving landscape of biopharmaceutical mergers and acquisitions. In the episode, Cheryl highlights an uptick in pre-M&A activity, as major pharmaceutical companies increasingly leverage license and option agreements to strengthen their pipelines and product portfolios while positioning themselves for potential future acquisitions.
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts

Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|

Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
